Use of the Genotype® MTBDRplus assay to assess drug resistance of Mycobacterium tuberculosis isolates from patients in rural Uganda

BMC Clinical Pathology

Volumn 10, Issue , 2010, Pages

  Bazira, Joel ^a   Asiimwe, Benon B ^b   Joloba, Moses L ^b   Bwanga, Fred ^b   Matee, Mecky I ^c  

^a MBARARA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Uganda)

^b MAKERERE UNIVERSITY   (Uganda)

^c MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; RIFAMPICIN;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; ASSAY; BACTERIAL GENE; BACTERIAL MUTATION; BACTERIUM ISOLATE; BIOMEDICAL TECHNOLOGY ASSESSMENT; FEMALE; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; RPOB GENE; RURAL POPULATION; TUBERCULOSIS; UGANDA;

EID: 77955218461     PISSN: 14726890     EISSN: 14726890     Source Type: Journal    
DOI: 10.1186/1472-6890-10-5     Document Type: Article

References (20)

1. Anti-tuberculosis drug resistance in the world. Fourth global report WHO/HTM/TB/2008.394. World Health Organization, Geneva
2. Global tuberculosis control: surveillance, planning, financing. World Health Organisation, Geneva: WHO 2009
3. Determination of drug susceptibility and DNA fingerprint patterns of clinical isolates of Mycobacterium tuberculosis from Kampala, Uganda. MLWC Joloba DM Cave KD Eisenach JL Johnson A Okwera A Morrissey S Bajaksouzian J Feagin R Mugerwa, et al. East Afr Med J 2000 77 111 115 10774085
4. Rate and amplification of drug resistance among previously-treated patients with tuberculosis in Kampala, Uganda. BAI Temple S Ogwang H Nabanjja S Kayes S Nakubulwa W Worodria J Levin M Joloba A Okwera, et al. Clin Infect Dis 2008 47 1126 1134 10.1086/592252 18808360
5. Mycobacterium tuberculosis spoligotypes and drug susceptibility pattern of isolates from tuberculosis patients in peri-urban Kampala, Uganda. BB Asiimwe, et al. BMC Infect Dis 2008 8 101 10.1186/1471-2334-8-101 18662405
6. Comparison of two commercially available DNA line probe assays for detection of multidrug-resistant Mycobacterium tuberculosis. JMH Makinen M Marjamaki MK Viljanen H Soini, J Clin Microbiol 2006 44 2 350 352 10.1128/JCM.44.2.350-352.2006 16455882
7. Genotype MTBDRplus: a further step toward rapid identification of drug-resistant Mycobacterium tuberculosis. PPF Miotto DM Cirillo GB Migliori, J Clin Microbiol 2008 46 1 393 394 10.1128/JCM.01066-07 17977988
8. Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa. MAH Barnard G Coetzee R O'Brien ME Bosman, Am J Respir Crit Care Med 2008 177 7 787 792 10.1164/rccm.200709-1436OC 18202343
9. National tuberculosis and Leprosy programme South Western Uganda. Republic of Uganda, M.o.H, Annual report 2008
10. Public health mycobacteriology: A guide for the level III laboratory. PTKG Kent, U. S. department of Health and Human Services. Centres for Disease Control, Atlanta, Ga Centres for Disease Control, Atlanta, Ga 1985
11. Manual of the National Tuberculosis and Leprosy programme in Uganda for district TB/Leprosy supervisors. Republic of Uganda, M.o.H, First 1992
12. Laboratory services in tuberculosis control. Part 2. Microscopy. WHO document WHO/TB/98.258. Geneva
13. Anti-tuberculosis drug resistance surveillance in Uganda 1996-1997. GAM Bretzel U Wendl-Richter F Adatu T Aisu A van Wijnen V Sticht-Groh, Int J Tuberc Lung Dis 1999 3 9 810 815 10488890
14. Factors influencing Delayed diagnosis of tuberculosis in Mukono District Uganda. J Oola, Institute of Public Health 2001
15. Results of a national survey on drug resistance among pulmonary tuberculosis patients in Rwanda. ANVG Umubyeyi M Gasana P Basinga JP Zawadi J Gatabazi P Pauwels F Nzabintwali L Nyiramasarabwe K Fissette L Rigouts MJ Struelens F Portaels, Int J Tuberc Lung Dis 2007 11 2 189 194 17263290 (Pubitemid 46219283)
16. M. tuberculosis genotypic diversity and drug susceptibility pattern in HIV-infected and non-HIV-infected patients in northern Tanzania. GSMB Kibiki WM Dolmans JL de Beer M Boeree N Sam D van Soolingen C Sola AG Zanden, BMC Microbiol 2007 7 51
17. The white plague: down and out, or up and coming? J Murray, Am Rev Respir Dis 1989 140 1788 1795 2604302
18. Performance of the Genotype MTBDRPlus assay in the diagnosis of tuberculosis and drug resistance in Samara, Russian Federation. V Nikolayevskyy, et al. BMC Clin Pathol 2009 9 2 10.1186/1472-6890-9-2 19284561
19. Use of genotype MTBDR assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis clinical strains isolated in Italy. P Miotto, et al. J Clin Microbiol 2006 44 7 2485 91 10.1128/JCM.00083-06 16825369
20. Multiple infection with resistant and sensitive M. tuberculosis strains during treatment of pulmonary tuberculosis patients. GCQ-TN Baldeviano-Vidalon C Bonilla-Asalde D Gastiaburu-Rodriguez JE Pro-Cuba F Llanos-Zavalaga, Int J Tuberc Lung Dis 2005 9 10 1155 1160 16229228